Clarivate (NYSE:CLVT) Updates FY 2026 Earnings Guidance

Clarivate (NYSE:CLVT) updated its FY 2026 earnings guidance on Wednesday. The company provided earnings per share guidance of 0.700-0.800 for the period, compared to the consensus earnings per share estimate of 0.700. The company issued revenue guidance of $2.3 billion-$2.4 billion, compared to the consensus revenue estimate of $2.4 billion.

Analyst Ratings Changes

A number of brokerages have weighed in on CLVT. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Clarivate in a research report on Friday, March 27th. Citigroup decreased their target price on Clarivate from $4.25 to $2.80 and set a “neutral” rating for the company in a research report on Wednesday, March 4th. Royal Bank Of Canada decreased their target price on Clarivate from $5.00 to $3.00 and set a “sector perform” rating for the company in a research report on Wednesday, February 25th. The Goldman Sachs Group lowered shares of Clarivate from a “buy” rating to a “neutral” rating and reduced their price target for the company from $4.20 to $3.60 in a report on Thursday, January 8th. Finally, Barclays reduced their price target on shares of Clarivate from $4.00 to $2.40 and set an “underweight” rating for the company in a report on Wednesday, February 25th. Five equities research analysts have rated the stock with a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Clarivate has a consensus rating of “Reduce” and an average target price of $3.22.

Clarivate Trading Up 0.9%

Shares of NYSE CLVT opened at $2.89 on Friday. The company has a debt-to-equity ratio of 0.89, a current ratio of 0.84 and a quick ratio of 0.84. The stock has a market capitalization of $1.85 billion, a P/E ratio of -13.74 and a beta of 1.39. Clarivate has a 1-year low of $1.66 and a 1-year high of $4.77. The business has a fifty day moving average price of $2.47 and a 200 day moving average price of $2.95.

Clarivate (NYSE:CLVT) last issued its quarterly earnings data on Wednesday, April 29th. The company reported $0.18 earnings per share for the quarter, topping analysts’ consensus estimates of $0.14 by $0.04. The firm had revenue of $585.50 million during the quarter, compared to analysts’ expectations of $569.50 million. Clarivate had a positive return on equity of 8.76% and a negative net margin of 5.61%.The firm’s quarterly revenue was down 1.4% on a year-over-year basis. During the same period in the prior year, the business posted $0.14 EPS. Clarivate has set its FY 2026 guidance at 0.700-0.800 EPS. Equities research analysts expect that Clarivate will post 0.63 EPS for the current fiscal year.

Institutional Investors Weigh In On Clarivate

A number of hedge funds and other institutional investors have recently bought and sold shares of CLVT. Atairos Partners GP Inc. lifted its position in Clarivate by 195.3% during the fourth quarter. Atairos Partners GP Inc. now owns 10,232,667 shares of the company’s stock valued at $34,177,000 after acquiring an additional 6,767,667 shares during the last quarter. First Trust Advisors LP purchased a new stake in Clarivate during the fourth quarter valued at approximately $16,721,000. Balyasny Asset Management L.P. lifted its position in Clarivate by 827.6% during the third quarter. Balyasny Asset Management L.P. now owns 4,882,593 shares of the company’s stock valued at $18,700,000 after acquiring an additional 4,356,232 shares during the last quarter. Bank of America Corp DE lifted its position in Clarivate by 506.9% during the second quarter. Bank of America Corp DE now owns 2,870,668 shares of the company’s stock valued at $12,344,000 after acquiring an additional 2,397,670 shares during the last quarter. Finally, Man Group plc lifted its position in Clarivate by 228.1% during the second quarter. Man Group plc now owns 3,091,139 shares of the company’s stock valued at $13,292,000 after acquiring an additional 2,148,943 shares during the last quarter. Hedge funds and other institutional investors own 85.72% of the company’s stock.

Clarivate Company Profile

Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.

Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.